IPA Stock Earnings: ImmunoPrecise Antibodies Beats EPS, Beats Revenue for Q2 2024
Source: iQoncept / Shutterstock
ImmunoPrecise Antibodies (NASDAQ:IPA) just reported results for the second quarter of 2024.
- ImmunoPrecise Antibodies reported earnings per share of -7.4 cents. This was above the analyst estimate for EPS of -10 cents.
- The company reported revenue of $4.62 million.
- This was 6.74% better than the analyst estimate for revenue of $4.33 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2023/12/ipa-stock-earnings-immunoprecise-antibodies-for-q2-of-2024/.
©2023 InvestorPlace Media, LLC